Cytochrome P450 3A4 Genotype, Blood
NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.
An aid to clinicians in determining therapeutic strategies for drugs that are metabolized by CYP3A4, including atorvastatin, simvastatin, and lovastatin
Testing Algorithm Delineates situation(s) when tests are added to the initial order. This includes reflex and additional tests.
The following algorithms are available in Special Instructions:
-Informed Consent for Genetic Testing
-Multiple Whole Blood EDTA Genotype Tests
-Cytochrome P450 3A4 and 3A5 Known Drug Interaction Chart
Special Instructions and Forms Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test
Polymerase Chain Reaction (PCR) 5’-Nuclease End-Point Allelic Discrimination Analysis
(PCR is utilized pursuant to a license agreement with Roche Molecular Systems, Inc.)
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
CYP3A4 Genotype, B
Cytochrome P450 3A4